These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19027322

  • 21. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
    Djoba Siawaya JF, Chegou NN, van den Heuvel MM, Diacon AH, Beyers N, van Helden P, Walzl G.
    Cytokine; 2009 Aug; 47(2):132-6. PubMed ID: 19570688
    [Abstract] [Full Text] [Related]

  • 22. Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects.
    Pott GB, Sailer CA, Porat R, Peskind RL, Fuchs AC, Angel JB, Skolnik PR, Jacobson MA, Giordano MF, Lebeaut A, Grint PC, Dinarello CA, Shapiro L.
    Eur Cytokine Netw; 2007 Jun; 18(2):49-58. PubMed ID: 17594937
    [Abstract] [Full Text] [Related]

  • 23. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.
    Hasan Z, Jamil B, Khan J, Ali R, Khan MA, Nasir N, Yusuf MS, Jamil S, Irfan M, Hussain R.
    Scand J Immunol; 2009 Mar; 69(3):259-67. PubMed ID: 19281538
    [Abstract] [Full Text] [Related]

  • 24. Changes in serum cytokine levels in active tuberculosis with treatment.
    Deveci F, Akbulut HH, Turgut T, Muz MH.
    Mediators Inflamm; 2005 Oct 24; 2005(5):256-62. PubMed ID: 16258192
    [Abstract] [Full Text] [Related]

  • 25. Peripheral immune response in pulmonary tuberculosis.
    Aktas E, Ciftci F, Bilgic S, Sezer O, Bozkanat E, Deniz O, Citici U, Deniz G.
    Scand J Immunol; 2009 Sep 24; 70(3):300-8. PubMed ID: 19703020
    [Abstract] [Full Text] [Related]

  • 26. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
    Visser ME, Texeira-Swiegelaar C, Maartens G.
    Int J Tuberc Lung Dis; 2004 Feb 24; 8(2):260-2. PubMed ID: 15139457
    [Abstract] [Full Text] [Related]

  • 27. Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy.
    Chowdhury IH, Ahmed AM, Choudhuri S, Sen A, Hazra A, Pal NK, Bhattacharya B, Bahar B.
    Mol Immunol; 2014 Nov 24; 62(1):159-68. PubMed ID: 25019566
    [Abstract] [Full Text] [Related]

  • 28. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis.
    Prabhu Anand S, Selvaraj P, Narayanan PR.
    Cytokine; 2009 Feb 24; 45(2):105-10. PubMed ID: 19091593
    [Abstract] [Full Text] [Related]

  • 29. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity.
    Nirmala R, Narayanan PR, Mathew R, Maran M, Deivanayagam CN.
    Tuberculosis (Edinb); 2001 Feb 24; 81(5-6):343-52. PubMed ID: 11800585
    [Abstract] [Full Text] [Related]

  • 30. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy.
    Brahmbhatt S, Black GF, Carroll NM, Beyers N, Salker F, Kidd M, Lukey PT, Duncan K, van Helden P, Walzl G.
    Clin Exp Immunol; 2006 Nov 24; 146(2):243-52. PubMed ID: 17034576
    [Abstract] [Full Text] [Related]

  • 31. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.
    Kim HJ, Chung DH, Kim MJ, Jang JH, Kim YW, Han SK, Shim YS, Yim JJ.
    Int J Tuberc Lung Dis; 2008 Sep 24; 12(9):1071-6. PubMed ID: 18713507
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption.
    Barqasho B, Nowak P, Tjernlund A, Kinloch S, Goh LE, Lampe F, Fisher M, Andersson J, Sönnerborg A, QUEST study group.
    HIV Med; 2009 Feb 24; 10(2):94-102. PubMed ID: 19200172
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.
    Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, Abgrall S, Delcey V, Vicaut E, Sereni D, Autran B, PARADOX Study Group.
    J Immunol; 2009 Sep 15; 183(6):3915-23. PubMed ID: 19726768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.